The aim of this study was to investigate the relationship between preoperative serum ferritin levels, clinico-pathological parameters and survival analysis of patients with colorectal cancer. Ninety-four patients (57 males) with a mean age of 65 years (39-87 years) underwent 63 curative and 31 palliative operations. Follow-up was at least 5 years. Patients were categorized with normal (30-215 ng/mL in men and 11-148 ng/mL in women), low, or high serum ferritin levels. Prognostic evaluation was undertaken with stratified survival analysis and Cox's regression model. Twenty-nine of the patients (30.9%) had raised ferritin levels and 14 (14.9%) had low values. Comparisons of the survival curves showed significant differences in stage C disease; specifically, patients with either low or high ferritin levels had a shorter survival than patients with normal levels. Patients who underwent palliative surgery and had high ferritin serum values also had a shorter survival. In multivariate analysis, the variables with a negative effect on survival were stage, serum ferritin levels and age. Our data suggest that patients with advanced colorectal cancer having normal preoperative serum ferritin levels may have a better prognosis, although the prognostic value related to this association requires further investigation.
Lorenzi, M., Lorenzi, B., & Vernillo, R. (2006). Serum ferritin in colorectal cancer patients and its prognostic evaluation. THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 21(4), 235-241.
Scheda prodotto non validato
Scheda prodotto in fase di analisi da parte dello staff di validazione
|Titolo:||Serum ferritin in colorectal cancer patients and its prognostic evaluation|
|Citazione:||Lorenzi, M., Lorenzi, B., & Vernillo, R. (2006). Serum ferritin in colorectal cancer patients and its prognostic evaluation. THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 21(4), 235-241.|
|Appare nelle tipologie:||1.1 Articolo in rivista|